Radiographer uses 3D printing to meet demand for PPE May 22, 2020 -- A resourceful radiographer from the U.K. has used his home 3D printer to create hundreds of face shields for hospitals, care homes, and other institutions in urgent need of personal protective equipment (PPE) to care for COVID-19 patients.
Medis Medical acquires AMID May 12, 2020 -- Medical imaging software developer Medis Medical Imaging Systems has acquired Advanced Medical Imaging Development (AMID), a cardiac and cardiovascular imaging software developer based in Italy.
TeraRecon unveils lung density analysis for COVID-19 May 7, 2020 -- Advanced visualization and artificial intelligence (AI) software developer TeraRecon has introduced two new lung density analysis software applications to aid in the assessment and follow-up care of patients with COVID-19.
3D printing, VR facilitate pediatric lung operation May 6, 2020 -- The combination of 3D printing and virtual reality (VR) technology can enable anesthesiologists to produce a personalized and more appropriate airway plan for lung operations on pediatric patients, researchers stated in a new case report published in the European Journal of Anaesthesiology. Discuss
Median continues revenue growth run April 29, 2020 -- Imaging software developer Median Technologies prolonged its streak of six consecutive quarters of revenue growth in the first quarter of 2020.
Brainlab gets CE Mark for ExacTrac Dynamic April 21, 2020 -- Image-guided therapy developer Brainlab has received the CE Mark for its ExacTrac Dynamic patient positioning and monitoring system for use in radiation therapy.
How 3D fusion can aid diagnosis of cardiac disease April 20, 2020 -- Swiss investigators have found a 3D image fusion technique combining CT and MRI data enables clinicians to better diagnose coronary artery disease. They published their results on 16 April in Radiology: Cardiothoracic Imaging. Discuss
Median receives 15M euros in loan funding April 20, 2020 -- Imaging software developer Median Technologies has received a disbursement of 15 million euros, the first tranche of a loan that the company plans to use to further develop its iBiopsy product.